Aortic valve replacement in patients aged ≥ 70 years carries significant in-hospital and late mortality risks, highlighting the need for individually tailored approaches and shorter cardiopulmonary bypass times.
No takes yet. Share an insight, caveat, or question.
Substantial mortality after AVR in patients ≥70 years warrants caution; leaves open whether tailored strategies reduce risk.
Aydın et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: